Skip to content

Home
Publications
The Group
JJD
Opportunities
Contact
Login

Search for:

Close search bar

Neuronally Derived Extracellular Vesicle alpha-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease

September 12, 2024July 16, 2026

by Jason Davis

S. Yan, C. Jiang, A. Janzen, J.J. Davis, T.R. Barber, A. Seger, M. Sommerauer, K. Marek, M.T Hu, W.H Oertel, G.K. Tofaris
JAMA Neurology. 2024, 81, 1, 59-68

Posted in 2024, Diagnostics, Show All

Post navigation

Antigen-Mimic Nanoparticles in Ultrasensitive on-Chip Integrated Anti-p53 Antibody Quantification

Platinum-Selenopeptide Interfaces in Support of High Fidelity Electrochemical Biomarker Quantification in Complex Biological Matrices

Search

CLICK TO FILTER

© Davis Group Oxford Chemistry, 2023

Copyright © 2026 JJD Group

Scroll to top